July 1, 2013-PoGo
“Making DSM-5. Concepts and controversies”
“Considering the economy of DSM alternatives.”
Now place the same subcontractor in relation to the NAMI as described here and consider secondary benefince?
*U.T. seems to be making a distinction between academic and commercial enterprise.
“through a film darkly..”1BOM:
the need for academic/pharma firewall
-In all probability we won’t be able to resolve the harms from contractors or subcontractors but the idea is to set a foundation of checks and balences for the future generations. At the same time provide a means for objective science via open source or open data.